We are thrilled to shine the spotlight on some of the achievements noted in several of Novo Nordisk (NN) global studies conducted, that have Malaysian sites demonstrating outstanding clinical trial performance throughout 2024.
Currently browsing: Our Latest News
Malaysia Receives Five New First-in-Human Clinical Research
Malaysia has received five new First-in-Human (FIH) trials through Clinical Research Malaysia (CRM), marking the highest number of FIH clinical research ever achieved, said Health Minister Datuk Seri Dr Dzulkefly Ahmad.
Early Phase Exploration Kicks Off in Malaysia
The clinical research industry is a booming one, with a global value standing at over US$480bil (RM368bil) last year, and it is projected to grow 6.5% annually.
Navigating the Frontiers of Clinical Research
It all started with a single file cabinet at the Sarawak General Hospital (SGH) for Dr Chew Lee Ping.
Taking One for the Team
WHEN Syed Johari Syed Jamaludin found out he had idiopathic pulmonary fibrosis (IPF), he knew he would die soon
The question was how soon?
Sarawak General Hospital Achieves Milestone in First in Human Clinical Trials
Sarawak General Hospital (SGH), together with its Clinical Research Centre (CRC) celebrated a series of significant milestones in early phase clinical research, positioning itself as a key player in the global First-in-Human (FIH) clinical trial landscape.
Malaysians Creating Waves at International Oncology Congress
Professor Dr Serena Nik-Zainal, a Malaysian Scientist who is based in the United Kingdom has received the prestigious ESMO Award for Translational Research during the Opening Ceremony at the European Society of Medical Oncology (ESMO) Congress 2024
Re-organization of Clinical Operations, Clinical Research Malaysia
Clinical Research Malaysia is expanding in its business as we experience an increased volume of trials in the country. The business expansion has become inevitable due to the growth of sponsored research in the region and with Malaysia seen as a favorable site for multi-regional clinical trials.
CRM Trial Connect Conference 2024
The CRM Trial Connect 2024 is on its third consecutive year and was held in collaboration with the European Organization for Research & Treatment of Cancer (EORTC) and the National Cancer Center Japan. The conference was aimed to showcase Malaysia’s accomplishments in sponsored clinical research and promote collaborations between local and international clinical research stakeholders.
CRM and AstraZeneca Won the Prestigious Business Excellence Award 2024 for UK-Malaysia Partnership of the Year!
We are thrilled about this remarkable achievement at the fifth Business Excellence Award (BEA) 2024, hosted by the British Malaysian Chamber of Commerce (BMCC). AstraZeneca and Clinical Research Malaysia have won the prestigious UK-Malaysia Partnership of the Year Award, encompassing clinical trials, governance meetings, and site visits.